AMG National Trust Bank trimmed its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 24.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,534 shares of the conglomerate’s stock after selling 6,618 shares during the quarter. AMG National Trust Bank’s holdings in Danaher were worth $5,708,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also made changes to their positions in the company. Fort Pitt Capital Group LLC boosted its stake in Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after acquiring an additional 7,421 shares during the last quarter. Good Life Advisors LLC acquired a new position in shares of Danaher in the third quarter valued at $217,000. Oak Thistle LLC bought a new stake in shares of Danaher in the second quarter valued at approximately $363,000. Harvest Portfolios Group Inc. boosted its position in shares of Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after acquiring an additional 2,465 shares in the last quarter. Finally, Diversified Trust Co boosted its stake in Danaher by 75.4% in the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock valued at $1,090,000 after buying an additional 1,874 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on the company. KeyCorp lifted their price target on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. TD Cowen upped their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. StockNews.com upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Wednesday, November 6th. Leerink Partners increased their price target on shares of Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Finally, Bank of America boosted their target price on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research note on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average price target of $287.16.
Danaher Stock Down 3.7 %
Shares of Danaher stock opened at $230.50 on Monday. The company has a 50 day moving average of $262.20 and a 200 day moving average of $260.57. The company has a market capitalization of $166.48 billion, a P/E ratio of 43.99, a P/E/G ratio of 4.24 and a beta of 0.85. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a 52-week low of $206.30 and a 52-week high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.02 earnings per share. As a group, research analysts forecast that Danaher Co. will post 7.51 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is currently 20.61%.
Insider Buying and Selling
In related news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 11.10% of the company’s stock.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Investing In Automotive Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Manufacturing Stocks Investing
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What is the S&P 500 and How It is Distinct from Other Indexes
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.